Generate Biomedicines has been AI-native since its founding in 2018. Hear from co-founder and CTO Gevorg Grigoryan about how the biotech company uses AI to its advantage.

Machine learning challenges cover everything from ethical issues to data quality and user acceptance concerns. Learn about seven common obstacles.

New capabilities including Agent Memory and extension to edge devices help the vendor compete for market share as it grows beyond its database roots.

New capabilities address the data retrieval accuracy and regulatory compliance issues that often stall initiatives, and could help distinguish the vendor from competitors.